Ramon Güimil García
Technik-/Wissenschafts-/F&E-Leiter bei Hummingbird Diagnostics GmbH
Aktive Positionen von Ramon Güimil García
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2009 | - |
Karriereverlauf von Ramon Güimil García
Ehemalige bekannte Positionen von Ramon Güimil García
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The European Molecular Biology Laboratory | Corporate Officer/Principal | 01.01.1995 | - |
Nucleic Acid Synthesis Group | Corporate Officer/Principal | 01.01.1990 | - |
Statistik
International
Deutschland | 4 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Health Technology |
Nucleic Acid Synthesis Group |
- Börse
- Insiders
- Ramon Güimil García
- Erfahrung